Detalhe da pesquisa
1.
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 116(4): 837-848, 2023 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657497
2.
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
PLoS One
; 16(7): e0252041, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34197475
3.
Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment.
J Immunother Cancer
; 5(1): 54, 2017 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28716137
4.
Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know.
Am J Med
; 128(9): 943-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25820169